u-pirata.ru


Neo Genetics Stock

The genetic testing company has been unprofitable as it spent heavily (but that's only part of the story). NVTAEXASNEO. NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United Stat Show More. Compare. Quote Overview ; 52 Wk Low: ; 52 Wk High: ; 20 Day Avg Vol: , ; Market Cap: B ; Dividend: (%). Stock Overview ; Symbol. NEO ; Exchange. Nasdaq ; Market Cap. b ; Last Price. $ ; Week Range. $ - $ NeoGenomics, Inc. operates a network of clinical laboratories that specializes in cancer genetics diagnostic testing services.

NeoGenomics Inc is listed in the Testing Laboratories sector of the NASDAQ with ticker NEO. The last closing price for NeoGenomics was $ Over the last. NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. It operates through the Clinical. Real time NeoGenomics (NEO) stock price quote, stock graph, news & analysis NeoGenomics is a provider of genetic testing, specializing in cancer diagnostics. NeoGenomics Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. Trading Statistics ; Stock Price. Open: ; Volume. Stock: , ; Volatility. Today's Stock Vol: ; Corporate. Div. Yield: ; Descriptive. Type: Common. NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. Discover real-time NeoGenomics, Inc. Common Stock (NEO) stock prices, quotes, historical data, news, and Insights for informed trading and investment. Neogenomics Inc NEO:NASDAQ ; Close. quote price arrow up + (+%) ; Volume. , ; 52 week range. - Find the latest NeoGenomics, Inc. (NEO) stock quote, history, news and other vital information to help you with your stock trading and investing. NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely.

NeoGenomics - 20 Year Stock Price History | NEO · The all-time high NeoGenomics stock closing price was on February 12, · The NeoGenomics week high. Neogenomics Inc NEO:NASDAQ ; Open ; Day High ; Day Low ; Prev Close ; 52 Week High Company Overview. NeoGenomics, Inc. specializes in cancer genetics Nasdaq: NEO. Price. Change. (%). Volume. k. Day Range. The intrinsic value of one NEO stock under the Base Case scenario is USD. Compared to the current market price of USD, Neogenomics Inc is Overvalued. (NASDAQ:NEO) Q1 Earnings Call Transcript April 30, NeoGenomics, Inc. beats earnings expectations. Reported EPS is $, expectations were $ You can buy NeoGenomics Inc (NEO) stock and many other stocks or ETFs on Stash NeoGenomics, Inc. is an operator of a network of cancer-focused genetic testing. On Friday 08/23/ the closing price of the Neogenomics IncShs share was $ on BTT. Compared to the opening price on Friday 08/23/ on BTT of $ The current price of NEO is USD — it has increased by % in the past 24 hours. Watch NeoGenomics, Inc. stock price performance more closely on the. NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. It operates through the.

About NEO. NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. It operates through. NeoGenomics stock analysis. $ Close:$(%). The market cap of NeoGenomics (NEO) is approximately B. What services does NeoGenomics, Inc. offer? NeoGenomics offers cancer genetics testing, including. Needham & Company LLC restated their buy rating on shares of NeoGenomics (NASDAQ:NEO Get Rating) in a research report report published on Wednesday morning. genetics. Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California.

The high in the last 52 weeks of Neogenomics stock was According to the current price, Neogenomics is % away from the week high. What are. NeoGenomics, Inc. specializes in cancer genetics testing and information services. The Company provides one of the most comprehensive oncology-focused. $ FLGT %. Guardant Health Inc. $ GH %. Qiagen NV. $ QGEN %. Myriad Genetics, Inc. $ MYGN %. Illumina Inc. $ ILMN. genetics testing services. As a leading provider in precision medicine VANGUARD INDEX FUNDS - Vanguard Total Stock Market Index Fund Investor Shares. About NEO. NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. It operates through. Easy onboarding, no account minimums, secure and simple stock investing NeoGenomics (NASDAQ:NEO Get Rating) and BioNano Genomics, Inc. WT EXP NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. It operates through the Clinical. NeoGenomics, Inc. specializes in cancer genetics testing and information services, providing one of the most comprehensive oncology-focused testing menus in. NeoGenomics, Inc. operates a network of clinical laboratories that specializes in cancer genetics diagnostic testing services. Discover real-time NeoGenomics, Inc. Common Stock (NEO) stock prices, quotes, historical data, news, and Insights for informed trading and investment. The genetic testing company has been unprofitable as it spent heavily (but that's only part of the story). NVTAEXASNEO. NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of. The current price of NEO is USD — it has increased by % in the past 24 hours. Watch NeoGenomics, Inc. stock price performance more closely on the. NeoGenomics Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. Stock Activity ; Open: ; Day Low: ; Day High: ; 52 Wk Low: ; 52 Wk High: NeoGenomics (NASDAQ:NEO) Stock Quotes, Forecast and News Summary ; Day Range, $ - $ ; 52 Wk Range, - ; Market Cap, $B ; P/E Ratio, -. NeoGenomics (NASDAQ:NEO) First Quarter Results Key Financial Results Revenue: US$m (up 14% from 1Q NeoGenomics (NASDAQ:NEO) Stock Quotes, Forecast and News Summary ; Day Range, $ - $ ; 52 Wk Range, - ; Market Cap, $B ; P/E Ratio, -. NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company. NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. You can buy NeoGenomics Inc (NEO) stock and many other stocks or ETFs on Stash NeoGenomics, Inc. is an operator of a network of cancer-focused genetic testing. NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. Stock Overview ; Symbol. NEO ; Exchange. Nasdaq ; Market Cap. b ; Last Price. $ ; Week Range. $ - $ The intrinsic value of one NEO stock under the Base Case scenario is USD. Compared to the current market price of USD, Neogenomics Inc is Overvalued. See the latest NeoGenomics Inc stock price (NEO:XNAS), related news, valuation, dividends and more to help you make your investing decisions. NeoGenomics (NEO) Quote Overview» More Research» NeoGenomics (NEO) Price Target Stock Forecast Medical - Biomedical and Genetics. Industry Rank by ABR. NeoGenomics Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. NeoGenomics, Inc.'s stock symbol is NEO and currently trades under NASDAQ. It's current price per share is approximately $ How much money does NeoGenomics. NeoGenomics, Inc. is a clinical laboratory, which specializes in cancer genetics diagnostic testing and pharma services. Real time NeoGenomics (NEO) stock price quote, stock graph, news & analysis NeoGenomics is a provider of genetic testing, specializing in cancer diagnostics.

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories providing genetic and molecular testing services to hospitals, pathologists. Trading Statistics ; Industry: Diagnostics & Research ; Shares Oustanding: M ; Share Float: M.

Discover High Yield Savings Referral Bonus | Swimming Pool Financing Terms

1 2 3 4 5


Copyright 2013-2024 Privice Policy Contacts SiteMap RSS